People · Operator
Named in public records as an officer, director or promoter · active 2012–2018 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Harpoon Therapeutics, Inc. | — | Biotechnology | Series D+ | $220.3M | $1.4B | 2018 |
| IlluminOss Medical Inc | — | Other | Series B | $39.9M | $83.0M | 2012 |
Ron R. Hunt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ron R. Hunt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Fouad Azzam | 1 | 8 |
| Rajeev Dadoo | 1 | 7 |
| Alan Colowick | 1 | 7 |
| Enrico Petrillo | 1 | 6 |
| Lee Wrubel | 1 | 5 |
| Mark Chin | 1 | 4 |
| Ron Hunt | 1 | 4 |
| Daniel Omstead | 1 | 4 |
| Luke Walker | 1 | 3 |
| Gerald McMahon | 1 | 3 |
| Robert A. Rabiner | 1 | 2 |
| Scott Myers | 1 | 2 |
| Harry T. Rein | 1 | 2 |
| Daniel R. Omstead | 1 | 2 |
| Lee R. Wrubel | 1 | 2 |
| Andrew Robbins | 1 | 2 |
| Joseph Bailes | 1 | 2 |
| Dirk Kuyper | 1 | 2 |
| R. Scott Rader | 1 | 2 |
| Jonathan Drachman | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.